BC
DXCM icon

Bartlett & Co’s DexCom DXCM Stock Holding History

Bartlett & Co’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$27K Buy
+215
New +$22K ﹤0.01% 812
2023
Q3 		– Sell
-44
Closed -$6K – 1145
2023
Q2 		$6K Hold
44
– – ﹤0.01% 968
2023
Q1 		$5K Hold
44
– – ﹤0.01% 888
2022
Q4 		$5K Hold
44
– – ﹤0.01% 914
2022
Q3 		$4K Hold
44
– – ﹤0.01% 946
2022
Q2 		$3K Buy
+44
New +$4.02K ﹤0.01% 1111
2021
Q3 		– Sell
-8
Closed -$1K – 960
2021
Q2 		$1K Hold
8
– – ﹤0.01% 910
2021
Q1 		$1K Hold
8
– – ﹤0.01% 934
2020
Q4 		$1K Buy
+8
New +$714 ﹤0.01% 995

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bartlett & Co's DXCM Position: Q4 2023 in Review

Bartlett & Co opened a new position in DexCom (DXCM) in Q4 2023: 215 shares worth $27K. The stake represents ﹤0.01% of the portfolio and ranks #812 among its holdings. This is a return to the name: Bartlett & Co previously reported a position in DXCM as recently as Q2 2023.

Bartlett & Co first reported a position in DXCM in Q4 2020 and has held it in 9 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Bartlett & Co held 215 shares of DexCom worth $27K as of Q4 2023.
  • DexCom was a new Bartlett & Co position in Q4 2023.
  • DexCom made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #812 holding.
  • Bartlett & Co first reported a position in DexCom in Q4 2020 and has held it in 9 quarters since.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.